Rankings
▼
Calendar
ALDX FY 2025 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$318M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$251,993
Operating Income
-$35M
Net Income
-$34M
EPS (Diluted)
$-0.56
Cash Flow
Operating Cash Flow
-$33.3T
Free Cash Flow
-$33.3T
Stock-Based Comp.
$6.1T
Balance Sheet
Total Assets
$72.1T
Total Liabilities
$27.8T
Stockholders' Equity
$44.3T
Cash & Equivalents
$70.0T
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$251,993
$0
—
Operating Income
-$35M
-$60M
+41.3%
Net Income
-$34M
-$56M
+39.4%
← Q4 2024
All Quarters
Q1 2025 →